SEARCH BUTTON
HOME > IQS TECH TRANSFER > TEAM > Cristina Fornaguera Puigvert, PhD

Cristina Fornaguera Puigvert, PhD

Associate Professor
+34932672000

RESEARCH LINES

  • Polymeric nanosystems for biomedical applications.
  • Design of advanced drug delivery systems.
  • Design of non-viral vectors for gene therapy.
  • Optimisation of nanoformulations with organ-specific vectorisation.
  • Formulation of mRNA vaccines based on nanosystems.
  • Design of new immunotherapies for cancer treatment

 

MEMBER OF:

GEMAT

Grup d'Enginyeria de Materials

School of Engineering

Materials Engineering

Its activities focus on three main areas: the development of new functional materials, surface engineering and biomaterials.

LATEST PROJECTS

DemiRNApy (Role of miRNAs in the anterior cingulate cortex, as peripheral biomarkers, and their targeted modulation by nano-tools as a antidepressant therapy)

Role of microRNAs in the brain , as peripheral biomarkers and as nano-tools as novel antidepressant therapy
Funding Agency:
Research Group Link:
Materials Engineering (GEMAT)

TumorOut (Innovative mRNA vaccine against lung cancer)

Innovative platform of targeted polymeric nanoparticles for efficient personalized therapy against lung cancer
Funding Agency:
Research Group Link:
Materials Engineering (GEMAT)

ZwiRNA (Nanopartículas zwiteriónicas como vacunas de ARNm contra el cáncer pulmonar)

Desarrollo de Nanopartículas zwiteriónicas de Poli(beta-aminoester) como vacunas de mRNA para tratar el cáncer de pulmón de células no pequeñas (zwiRNA).
Funding Agency:
Research Group Link:
Materials Engineering (GEMAT)
1 2 3
Search more projects

LINKED NEWS

Research

New personalized therapeutic vaccine for lung cancer

07/03/2023
IQS professor Dr Cristina Fornaguera is leading the European project TumorOUT to design a new immunotherapy based on polymer nanoparticles with encapsulated antigenic mRNAs to holistically attack different mechanisms of lung cancer.
READ FULL NEW
Research

Micro RNAs to Treat Depression

09/01/2023
IQS is one of the members of the DemiRNApy project, one of the 36 research projects selected by the Fundació Marató TV3 charitable fundraising drive in its 2021 edition dedicated to mental health, with the aim of developing nanotherapies to treat depression.
READ FULL NEW
Research

Invisible, Targeted mRNA Vaccines

03/11/2022
The GEMAT group at IQS is working on the zwiRNA project with the goal of designing a new state-of-the-art therapeutic vaccine for the treatment of lung cancer.
READ FULL NEW
Interview

Interview with Dr José Rodrigo Magaña and Dr Cristina Fornaguera

10/06/2022
"My contribution to the ANTIEMT project is designing genetic material transporters. They are invisible polymers for most of the body's cells, except for tumor cells, to which they are targeted as ‘ninjas.’"
READ FULL NEW
News

Confocal Microscopy

05/02/2021
IQS has a Leica SP8 Confocal Scanning Microscope used for any application that involves the analysis of images that emit fluorescence, on their own or if they have been previously labeled with fluorophores, that allows the analysis of materials and biomaterials in addition to the analysis of biological tissues and cell culture.
READ FULL NEW
Interview

Dr Borrós and Dr Fornaguera, leaders of the CoviNanoVax project

08/01/2021
“We have our mRNA encapsulated, which appears from the outset that it will be immunogenic, stable and non-toxic, with stable nanoparticles at 4ºC, and obtained through an easily scalable process.“
READ FULL NEW
Search all news